Pfizer Inc. (PFE) Q4 2017 Earnings Results

Pfizer Beats on EPS, Stock Down 3.13%

Pfizer's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 3.13%, likely due to the lack of revenue details and guidance, which may have raised concerns among investors about future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.62	N/A	+6.19%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed a cautious optimism about future growth driven by R&D investments. They emphasized the need to strengthen their product pipeline.

Management highlighted ongoing investments in R&D as a priority.

They noted the importance of maintaining strong product pipelines.

There was a focus on future opportunities in emerging markets.

Pfizer Beats on EPS, Stock Down 3.13%

Key numbers

Management commentary

Pfizer Inc.

More earnings this week

Pfizer Beats on EPS, Stock Down 3.13%

Key numbers

Management commentary